Scholars@Duke publication: A single genetic locus determines the efficacy of serum therapy against murine adenocarcinoma 755a.

A single genetic locus determines the efficacy of serum therapy against murine adenocarcinoma 755a.

Publication , Journal Article

Roloson, GJ; Chambers, CA; Haagensen, DE; Montelaro, RC; Bolognesi, DP

Published in: Haematol Blood Transfus

1979

Haematol Blood Transfus

0171-7111

1979

469 / 481

Germany

APA

Chicago

ICMJE

MLA

NLM

Roloson, G. J., Chambers, C. A., Haagensen, D. E., Montelaro, R. C., & Bolognesi, D. P. (1979). A single genetic locus determines the efficacy of serum therapy against murine adenocarcinoma 755a. Haematol Blood Transfus, 23, 469–481. https://doi.org/10.1007/978-3-642-67057-2_61

Roloson, G. J., C. A. Chambers, D. E. Haagensen, R. C. Montelaro, and D. P. Bolognesi. “A single genetic locus determines the efficacy of serum therapy against murine adenocarcinoma 755a.” Haematol Blood Transfus 23 (1979): 469–81. https://doi.org/10.1007/978-3-642-67057-2_61.

Roloson GJ, Chambers CA, Haagensen DE, Montelaro RC, Bolognesi DP. A single genetic locus determines the efficacy of serum therapy against murine adenocarcinoma 755a. Haematol Blood Transfus. 1979;23:469–81.

Roloson, G. J., et al. “A single genetic locus determines the efficacy of serum therapy against murine adenocarcinoma 755a.” Haematol Blood Transfus, vol. 23, 1979, pp. 469–81. Pubmed, doi:10.1007/978-3-642-67057-2_61.

Haematol Blood Transfus

0171-7111

1979

469 / 481

Germany